Report for: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa

Title	Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
Published in	PLOS ONE, May 2013
DOI	10.1371/journal.pone.0063057
Pubmed ID	23667572
Authors	Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C. Victor, Paul van Helden, Martin Groubusch, Robin Warren, Motasim Badri, Keertan Dheda
Abstract	Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patients with XDR-TB are scarce.

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	2	100%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Master	39	22%
Researcher	27	15%
Student > Bachelor	18	10%
Student > Ph. D. Student	17	10%
Student > Postgraduate	13	7%
Other	29	16%
Unknown	34	19%

Readers by discipline	Count	As %
Medicine and Dentistry	72	41%
Pharmacology, Toxicology and Pharmaceutical Science	11	6%
Agricultural and Biological Sciences	10	6%
Nursing and Health Professions	9	5%
Immunology and Microbiology	7	4%
Other	22	12%
Unknown	46	26%

PLOS